Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer Curnow

Showing results (11-20 of 52) with videos related to

Pageof 6
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 18, 2021
Elective surgery in patients with inherited bleeding disorders: A retrospective analysisLisa Clarke, Peta M Dennington, Jennifer Curnow
Seminars in Thrombosis and Hemostasis|February 4, 2016
Treatment of von Willebrand DiseaseJennifer Curnow, Leonardo Pasalic, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis|May 6, 2016
Type 2M and Type 2A von Willebrand Disease: Similar but DifferentEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Pathology|May 2, 2016
Laboratory tests used to help diagnose von Willebrand disease: an updateEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Expert Review of Hematology|November 12, 2024
Current and emerging therapies as potential treatment for people with von Willebrand diseaseEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Seminars in Thrombosis and Hemostasis|February 12, 2019
To Maintain or Cease Non-Vitamin K Antagonist Oral Anticoagulants Prior to Minimal Bleeding Risk Procedures: A Review of Evidence and RecommendationsYvonne Brennan, Emmanuel J Favaloro, Jennifer Curnow
American Journal of Hematology|March 20, 2017
2B or not 2B? A prothrombotic tendency masquerading as a bleeding disorderYvonne Brennan, Jennifer Curnow, Emmanuel J Favaloro
BMJ Case Reports|December 8, 2017
Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosisGeorgia McCaughan, Jennifer Massey, Ian Sutton, et al.
Multiple Sclerosis and Related Disorders|July 30, 2019
B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple SclerosisJennifer Massey, Yael Barnett, Jennifer Curnow, et al.
Pathology|January 23, 2019
Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negativesEmmanuel J Favaloro, Soma Mohammed, Jennifer Curnow, et al.
Pageof 6

Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 18, 2021
Elective surgery in patients with inherited bleeding disorders: A retrospective analysisLisa Clarke, Peta M Dennington, Jennifer Curnow
Seminars in Thrombosis and Hemostasis|February 4, 2016
Treatment of von Willebrand DiseaseJennifer Curnow, Leonardo Pasalic, Emmanuel J Favaloro
Seminars in Thrombosis and Hemostasis|May 6, 2016
Type 2M and Type 2A von Willebrand Disease: Similar but DifferentEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Pathology|May 2, 2016
Laboratory tests used to help diagnose von Willebrand disease: an updateEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Expert Review of Hematology|November 12, 2024
Current and emerging therapies as potential treatment for people with von Willebrand diseaseEmmanuel J Favaloro, Leonardo Pasalic, Jennifer Curnow
Seminars in Thrombosis and Hemostasis|February 12, 2019
To Maintain or Cease Non-Vitamin K Antagonist Oral Anticoagulants Prior to Minimal Bleeding Risk Procedures: A Review of Evidence and RecommendationsYvonne Brennan, Emmanuel J Favaloro, Jennifer Curnow
American Journal of Hematology|March 20, 2017
2B or not 2B? A prothrombotic tendency masquerading as a bleeding disorderYvonne Brennan, Jennifer Curnow, Emmanuel J Favaloro
BMJ Case Reports|December 8, 2017
Acquired haemophilia A complicating alemtuzumab therapy for multiple sclerosisGeorgia McCaughan, Jennifer Massey, Ian Sutton, et al.
Multiple Sclerosis and Related Disorders|July 30, 2019
B cell depletion therapy resulting in sustained remission of severe autoimmune complications following Alemtuzumab treatment of Multiple SclerosisJennifer Massey, Yael Barnett, Jennifer Curnow, et al.
Pathology|January 23, 2019
Laboratory testing for lupus anticoagulant (LA) in patients taking direct oral anticoagulants (DOACs): potential for false positives and false negativesEmmanuel J Favaloro, Soma Mohammed, Jennifer Curnow, et al.
Pageof 6